In one paragraphArticle in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors at 4 institutions in 3 countries.
Saidanxia AmutiSchool of Pharmaceutical Sciences, College of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920-1192, Japan.
Yohei SaitoSchool of Pharmaceutical Sciences, College of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920-1192, Japan.
Shuichi FukuyoshiSchool of Pharmaceutical Sciences, College of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920-1192, Japan.ORCID 0000-0002-9015-0920 Katsunori MiyakeSchool of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji 192-0392, Japan.ORCID 0000-0001-6199-8781 David J NewmanNatural Products Branch, Developmental Therapeutics Program, Center of Cancer Research, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD 21702-1201, USA.
Barry R O'KeefeNatural Products Branch, Developmental Therapeutics Program, Center of Cancer Research, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD 21702-1201, USA.ORCID 0000-0003-0772-4856 Kuo-Hsiung LeeNatural Products Research Laboratories, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7568, USA.ORCID 0000-0002-6562-0070 Kyoko Nakagawa-GotoSchool of Pharmaceutical Sciences, College of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa 920-1192, Japan.ORCID 0000-0002-1642-6538 Kanazawa University · JPNational Cancer Institute · USTokyo University of Pharmacy and Life Sciences · JPUniversity of North Carolina at Chapel Hill · US
Funding
Isolation of bioactive proteins from natural product extractsZIABC011472 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI OKEEFE, BARRY · 2012 to 2025
$7.8MJSPS KAKENHI Japan 18H02583JST SPRING JPMJSP2135Shibuya Science Culture and Sports Foundation N/A
6 · The paper itselfAbstract
Eight vilasinin-class limonoids, including the unusually chlorinated rubescins K-M (
Indexed as
LimoninsMeliaceaeCell Line, TumorHumansMolecular StructureLimoninsantiproliferative activitychlorinatedrubescins K–RTrichilia rubescensvilasinin-class limonoid
Identifiers
PMID38338394
PMCPMC10856392
OpenAlexW4391361325
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390